Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 3
2007 1
2008 2
2009 1
2010 1
2011 3
2013 3
2014 4
2015 3
2017 3
2018 5
2020 4
2021 5
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.
Fleurence J, Fougeray S, Bahri M, Cochonneau D, Clémenceau B, Paris F, Heczey A, Birklé S. Fleurence J, et al. Among authors: clemenceau b. J Immunol Res. 2017;2017:5604891. doi: 10.1155/2017/5604891. Epub 2017 Jan 5. J Immunol Res. 2017. PMID: 28154831 Free PMC article. Review.
CAR T Cell Therapy's Potential for Pediatric Brain Tumors.
Thomas P, Galopin N, Bonérandi E, Clémenceau B, Fougeray S, Birklé S. Thomas P, et al. Among authors: clemenceau b. Cancers (Basel). 2021 Oct 29;13(21):5445. doi: 10.3390/cancers13215445. Cancers (Basel). 2021. PMID: 34771608 Free PMC article. Review.
Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplant.
Jullien M, Coste-Burel M, Clemenceau B, Letailleur V, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Imbert BM, Ollier J, Grain A, Touzeau C, Moreau P, Béné MC, Vié H, Chevallier P. Jullien M, et al. Among authors: clemenceau b. EJHaem. 2022 Feb 17;3(2):484-487. doi: 10.1002/jha2.398. eCollection 2022 May. EJHaem. 2022. PMID: 35313664 Free PMC article.
[Can academic structures improve access to CAR-T cells?].
Le Guen C, Grain A, Le Calvez B, Saiagh S, Vrignaud F, Eveillard M, Clémenceau B, Zahar MB. Le Guen C, et al. Among authors: clemenceau b. Bull Cancer. 2024 Jan;111(1):62-72. doi: 10.1016/j.bulcan.2023.10.005. Epub 2023 Nov 28. Bull Cancer. 2024. PMID: 38030508 Review. French.
Systems-level conservation of the proximal TCR signaling network of mice and humans.
Nicolas P, Ollier J, Mori D, Voisinne G, Celis-Gutierrez J, Gregoire C, Perroteau J, Vivien R, Camus M, Burlet-Schiltz O, Gonzalez de Peredo A, Clémenceau B, Roncagalli R, Vié H, Malissen B. Nicolas P, et al. Among authors: clemenceau b. J Exp Med. 2022 Feb 7;219(2):e20211295. doi: 10.1084/jem.20211295. Epub 2022 Jan 21. J Exp Med. 2022. PMID: 35061003 Free PMC article.
Covid-19 and blood groups: ABO antibody levels may also matter.
Deleers M, Breiman A, Daubie V, Maggetto C, Barreau I, Besse T, Clémenceau B, Ruvoën-Clouet N, Fils JF, Maillart E, Doyen V, Mahadeb B, Jani JC, Van der Linden P, Cannie MM, Hayef N, Corazza F, Le Pendu J, El Kenz H. Deleers M, et al. Among authors: clemenceau b. Int J Infect Dis. 2021 Mar;104:242-249. doi: 10.1016/j.ijid.2020.12.025. Epub 2020 Dec 14. Int J Infect Dis. 2021. PMID: 33326874 Free PMC article.
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response.
Makanga DR, Jullien M, David G, Legrand N, Willem C, Dubreuil L, Walencik A, Touzeau C, Gastinne T, Tessoulin B, Le Gouill S, Mahé B, Gagne K, Chevallier P, Clemenceau B, Retière C. Makanga DR, et al. Among authors: clemenceau b. Oncoimmunology. 2021 Jun 14;10(1):1936392. doi: 10.1080/2162402X.2021.1936392. Oncoimmunology. 2021. PMID: 34178429 Free PMC article.
44 results